Cargando…
Synergistic Action of Gefitinib and GSK41364A Simultaneously Loaded in Ratiometrically-Engineered Polymeric Nanoparticles for Glioblastoma Multiforme
Glioblastoma Multiforme is a deadly cancer of glial cells with very low survival rates. Current treatment options are invasive and have serious side effects. Single drug treatments make the tumor refractory after a certain period. Combination therapies have shown improvements in treatment responses...
Autores principales: | Velpurisiva, Praveena, Rai, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462915/ https://www.ncbi.nlm.nih.gov/pubmed/30875975 http://dx.doi.org/10.3390/jcm8030367 |
Ejemplares similares
-
GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)
por: Velpurisiva, Praveena, et al.
Publicado: (2018) -
Simultaneous Presentation of Glioblastoma Multiforme in Divorced Spouses
por: Fehr, Cassie M., et al.
Publicado: (2022) -
Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
por: Kydd, Janel, et al.
Publicado: (2017) -
Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)